RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com
  

Hanmi Science Co Ltd patents

Recent patent applications related to Hanmi Science Co Ltd. Hanmi Science Co Ltd is listed as an Agent/Assignee. Note: Hanmi Science Co Ltd may have other listings under different names/spellings. We're not affiliated with Hanmi Science Co Ltd, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "H" | Hanmi Science Co Ltd-related inventors




Date Hanmi Science Co Ltd patents (updated weekly) - BOOKMARK this page
01/26/17Insulin conjugate using an immunoglobulin fragment
01/26/17Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same
01/26/17Insulin conjugate using an immunoglobulin fragment
08/11/16Novel fused pyrimidine derivatives for inhibition of tyrosine kinase activity
02/25/16Polypeptide complex comprising non-peptidyl polymer having three functional ends
10/22/15An improved process for preparation of physiologically active polypeptide complex
10/22/15An improved process for preparation of physiologically active polypeptide complex
10/15/15Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same
04/30/15Liquid formulation of highly concentrated long-acting human growth hormone conjugate
04/30/15Liquid formulation of highly concentrated long-acting human growth hormone conjugate
02/26/15Pharmaceutical composition for the prevention or treatment of non-alcoholic fatty liver disease
02/19/15Method of culturing e. coli cells for high density
02/12/15Novel fused pyrimidine derivatives for inhibition of tyrosine kinase activity
01/22/15Igg fc fragment for a drug carrier and the preparation thereof
01/22/15Igg fc fragment for a drug carrier and the preparation thereof
12/25/14Site-specific glp-2 conjugate using an immunoglobulin fragment
12/04/14Immunoglobulin fc variants
10/02/14Method for preparing physiologically active polypeptide complex
08/07/14Pharmaceutical composition for treating cancer, comprising interferon alpha conjugate
07/31/14Conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof
05/29/14Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same
05/08/14Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same
05/01/14Composition for treating diabetes comprising long-acting insulin conjugate and long-acting insulinotropic peptide conjugate
04/17/14Non-peptidyl polymer-insulin multimer and producing the same
10/31/13Liquid formulations of long acting interferon alpha conjugate
10/17/13Method for mass production of factor vii/viia
09/19/13Pharmaceutical composite formulation comprising hmg-coa reductase inhibitor and aspirin
08/15/13Method for purifying human granulocyte-colony stimulating factor from recombinant e. coli
06/27/13Quinoline or quinazoline derivatives with apoptosis inducing activity on cells
05/16/13Novel long-acting glucagon conjugate and pharmaceutical composition comprising the same for the prevention and treatment of obesity
05/09/13Liquid formulation of long-acting human growth hormone conjugate
05/09/13Novel fused pyrimidine derivatives for inhibition of tyrosine kinase activity
04/18/13Factor viia complex using an immunoglobulin fragment
03/21/13Pharmaceutical composition comprising amide derivative or pharmaceutically acceptable salt thereof
01/31/13Pharmaceutical formulation in the form of bilayered tablets comprising hmg-coa reductase inhibitor and irbesartan
01/31/13Long-acting interferon beta formulation using immunoglobulin fragment
01/31/13Insulin conjugate using an immunoglobulin fragment
01/24/13Long-acting human follicle-stimulating hormone formulation using immunoglobulin fragment
01/24/13Oral pharmaceutical composition comprising fenofibric acid and an alkalifying agent
12/27/12Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same
12/20/12Complex formulation for oral administration comprising probiotic formulation and 5-ht4 receptor agonist and the preparation thereof
11/29/12Oral complex composition comprising pseudoephedrine and levocetirizine
11/29/12Complex formulation comprising aspirin coated with barrier containing hydrophobic additive, and hmg-coa reductase inhibitor
11/22/12Liquid formulations for long-acting g-csf conjugate
11/22/12Liquid formulations for long-acting erythropoietin conjugate







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Hanmi Science Co Ltd in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Hanmi Science Co Ltd with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';